These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 32552834)

  • 1. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer.
    Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ
    Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
    Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
    Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.
    Yokoyama M; Chiba T; Zen Y; Oshima M; Kusakabe Y; Noguchi Y; Yuki K; Koide S; Tara S; Saraya A; Aoyama K; Mimura N; Miyagi S; Inoue M; Wakamatsu T; Saito T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Yokosuka O; Iwama A
    Oncotarget; 2017 Mar; 8(13):21315-21326. PubMed ID: 28423509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin remodeling by the histone methyltransferase EZH2 drives lung pre-malignancy and is a target for cancer prevention.
    Tellez CS; Picchi MA; Juri D; Do K; Desai DH; Amin SG; Hutt JA; Filipczak PT; Belinsky SA
    Clin Epigenetics; 2021 Feb; 13(1):44. PubMed ID: 33632299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells.
    Kondo Y; Shen L; Ahmed S; Boumber Y; Sekido Y; Haddad BR; Issa JP
    PLoS One; 2008 Apr; 3(4):e2037. PubMed ID: 18446223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway.
    Sun T; Zhang K; Pangeni RP; Wu J; Li W; Du Y; Guo Y; Chaurasiya S; Arvanitis L; Raz DJ
    Mol Cancer Res; 2021 Mar; 19(3):429-440. PubMed ID: 33298547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone Methyltransferase G9a Promotes the Development of Renal Cancer through Epigenetic Silencing of Tumor Suppressor Gene SPINK5.
    Li RG; Deng H; Liu XH; Chen ZY; Wan SS; Wang L
    Oxid Med Cell Longev; 2021; 2021():6650781. PubMed ID: 34336110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small nucleolar RNA signatures of lung tumor-initiating cells.
    Mannoor K; Shen J; Liao J; Liu Z; Jiang F
    Mol Cancer; 2014 May; 13():104. PubMed ID: 24886050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/β-catenin Signaling.
    Liu T; Wu X; Chen T; Luo Z; Hu X
    Clin Cancer Res; 2018 Apr; 24(7):1748-1760. PubMed ID: 28972040
    [No Abstract]   [Full Text] [Related]  

  • 11. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
    Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
    J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of histone methyltransferase G9a mediates transcriptional repression of Fgf21 gene by E4BP4 protein.
    Tong X; Zhang D; Buelow K; Guha A; Arthurs B; Brady HJ; Yin L
    J Biol Chem; 2013 Feb; 288(8):5417-25. PubMed ID: 23283977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of G9a inhibitor BIX‑01294 acting on U251 glioma cells.
    Guo AS; Huang YQ; Ma XD; Lin RS
    Mol Med Rep; 2016 Nov; 14(5):4613-4621. PubMed ID: 27748874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells.
    Cao YP; Sun JY; Li MQ; Dong Y; Zhang YH; Yan J; Huang RM; Yan X
    Acta Pharmacol Sin; 2019 Aug; 40(8):1076-1084. PubMed ID: 30765842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G9A promotes tumor cell growth and invasion by silencing CASP1 in non-small-cell lung cancer cells.
    Huang T; Zhang P; Li W; Zhao T; Zhang Z; Chen S; Yang Y; Feng Y; Li F; Shirley Liu X; Zhang L; Jiang G; Zhang F
    Cell Death Dis; 2017 Apr; 8(4):e2726. PubMed ID: 28383547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers.
    Altenberger C; Heller G; Ziegler B; Tomasich E; Marhold M; Topakian T; Müllauer L; Heffeter P; Lang G; End-Pfützenreuter A; Döme B; Arns BM; Klepetko W; Zielinski CC; Zöchbauer-Müller S
    Mol Cancer; 2017 Jan; 16(1):1. PubMed ID: 28093071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
    Toyokawa G; Cho HS; Masuda K; Yamane Y; Yoshimatsu M; Hayami S; Takawa M; Iwai Y; Daigo Y; Tsuchiya E; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
    Neoplasia; 2011 Oct; 13(10):887-98. PubMed ID: 22028615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy.
    Papait R; Serio S; Pagiatakis C; Rusconi F; Carullo P; Mazzola M; Salvarani N; Miragoli M; Condorelli G
    Circulation; 2017 Sep; 136(13):1233-1246. PubMed ID: 28778944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer.
    Chae YC; Kim JY; Park JW; Kim KB; Oh H; Lee KH; Seo SB
    Nucleic Acids Res; 2019 Feb; 47(4):1692-1705. PubMed ID: 30535125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Methyltransferase G9a Regulates Expression of Nuclear Receptors and Cytochrome P450 Enzymes in HepaRG Cells at Basal Level and in Fatty Acid Induced Steatosis.
    Pande P; Zhong XB; Ku WW
    Drug Metab Dispos; 2020 Dec; 48(12):1321-1329. PubMed ID: 33077425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.